In February 2021, Guerbet announced the launch of OptiProtect 3S (Smart Service Solutions), a range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane
Contrast Media Injectors Market Outlook

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have ...

Time January 19, 2022
Home
A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable vomiting, diarrhea and generalized weakness, but no specific upper or lower respiratory symptoms aside from mild shortness of breath.
Feature | Coronavirus (COVID-19) | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.
Clinical Case of the Month: 26 Year Old Man With Abdominal Pain

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable ...

Time January 19, 2022
Home
Sponsored Content | Case Study | Ultrasound Imaging
How Can Early Diagnosis of Fatty Liver be More Accurate and Accessible?

The most common cause of chronic liver disease? Nonalcoholic fatty liver disease (NAFLD). With 25% of the world’s ...

Time January 19, 2022
Home
n 2022, Imaging Technology News will be working hard to bring its audience exclusive, informative coverage, including the new Clinical Case of the Month section.
Blog | Radiology Business
Welcoming in the New Year

The New Year always brings change, which opens many doors to new possibilities. In 2022, Imaging Technology News will be ...

Time January 19, 2022
Home
For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used prostate cancer patients’ DNA to create a model that appears to predict who will have side effects from radiation.   
News | Prostate Cancer
Genetics Predicts Toxic Side Effects to Prostate Cancer Radiotherapy

January 19, 2022 — For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used ...

Time January 19, 2022
Home
Kernel Flow packages large-scale TD-fNIRS systems into a wearable form, delivering the next generation of noninvasive optical brain imaging devices.
News | Neuro Imaging
Wearable Device for Noninvasive Optical Brain Imaging

January 19, 2022 — Recent advances in brain imaging techniques facilitate accurate, high-resolution observations of the ...

Time January 19, 2022
Home
Videos | Magnetic Resonance Imaging (MRI)
VIDEO: New MRI Safer to Scan Patients With Implantable Devices

Orlando Simonetti, Ph.D., professor, cardiovascular medicine, worked with Siemens to help develop a new, lower-field ...

Time January 18, 2022
Home
Cydar EV Maps assists in the planning, real-time guidance, and post-procedure review of endovascular surgery.
News | Mobile C-Arms
Endovascular 3D Image Guidance Added to Philips Zenition Mobile C-arm

January 18, 2022 – Philips Healthcare announced physicians will now have access to advanced new 3D image guidance ...

Time January 18, 2022
Home
In a statement released today from the Association for Medical Imaging Management (AHRA), the association announced its decision to move the scheduled live AHRA CLIMB event to a virtual event. 
News | AHRA
AHRA Shifts Scheduled CLIMB Conference Virtual

January 18, 2022 — In a statement released today from the Association for Medical Imaging Management (AHRA), the ...

Time January 18, 2022
Home
Today, as part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the health of all women, the Center for Devices and Radiological Health (CDRH) is sharing its Health of Women Program Strategic Plan. CDRH initially issued a proposed strategic plan in September 2019 and has considered public feedback to inform this strategic plan, which lays out the framework to further the FDA’s mission by protecting and promoting the health of women, strengthening regulatory science, and
News | Women's Health
FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation

January 18, 2022 — The following statement was issued today by the U.S. Food and Drug Administration (FDA), and is ...

Time January 18, 2022
Home
Orlando Simonetti (right) works with MRI technologist Heather Hermiller to operate a new FDA-approved MRI machine that he helped develop. The machine has a lower magnetic field and larger patient opening, expanding access to patients who were previously unable to undergo MRI.
News | Magnetic Resonance Imaging (MRI)
New FDA-approved MRI Expands Access to Life-saving Imaging

January 18, 2022 — Magnetic resonance imaging (MRI) is a powerful medical tool that provides detailed images of ...

Time January 18, 2022
Home
UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market.
News | Breast Imaging
UE LifeSciences and Siemens Healthineers Launch iBreastExam in the U.S.

January 18, 2022 — UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers ...

Time January 18, 2022
Home
A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung cancer than in the past, supporting the need for increased use of screening to save lives, according to a Mount Sinai study published in JAMA Network Open in December.
News | Lung Imaging
Lung Cancer Death Decline Associated With Screening, Earlier Diagnosis and Surgery

January 17, 2022 — A recent, substantial decline in lung cancer deaths is associated with earlier diagnosis of lung ...

Time January 17, 2022
Home
57-Year-Old Woman Presented for Screening Mammography: Digital, A, and tomosynthesis, B, craniocaudal images showed 1.8 cm asymmetry (arrows) lateral left breast categorized as BI-RADS 0. C, Ultrasound left breast evaluation revealed normal fibroglandular tissue (arrow) believed to correlate with mammographic finding. D, Asymmetry effaced on rolled lateral craniocaudal imaging. Metallic BB marker noted at 12 o’clock position, anterior depth. Final assessment BI-RADS 1. Image courtesy of ARRS
News | Ultrasound Women's Health
Recalled Noncalcified Lesions: Ultrasound vs. Ultrasound Plus Mammography

January 17, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), radiologists should ...

Time January 17, 2022
Home
Virtual care may serve as a mechanism to increase health care access among under-resourced populations during the pandemic and beyond
News | Teleradiology
Telemedicine Expanded Access to Surgical Care During COVID-19 Pandemic, but Disparities Remain

January 17, 2022 — The COVID-19 pandemic has fundamentally changed the health care delivery landscape and shifted the ...

Time January 17, 2022
Home
The Task Force members have recently observed an unusual imaging pattern on FDG PET/CT or FDG PET/MR that may be due to COVID-19 infection. 
News | Coronavirus (COVID-19)
SNMMI Task Force Reports Possible Effect of Omicron Infection on FDG PET/CT Scans

January 17, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) issued a statement on Jan. 14 regarding ...

Time January 17, 2022
Home
Results of chest X-Rays, detected as Covid-19.
News | Coronavirus (COVID-19)
AI in the Fight Against COVID-19: Automatic Detection from Chest X-Ray Images Is Possible, Reports Incheon National University

January 14, 2022 — The COVID-19 pandemic took the world by storm in early 2020 and has become since then the leading ...

Time January 14, 2022
Home
International medical imaging IT and cybersecurity company Sectra has signed a contract for radiology imaging with an NHS consortium in Surrey and Sussex in the UK.
News | Enterprise Imaging
Consortium in the UK to Transform Patient Diagnostics with Sectra Imaging System

January 14, 2022 — International medical imaging IT and cybersecurity company Sectra has signed a contract for radiology ...

Time January 14, 2022
Home
Most AI for spotting pre-cancerous lesions in mammography scans don’t reveal any of their decision-making process (top). If they do, it’s often a saliency map (middle) that only tells doctors where they’re looking. A new AI platform (bottom) not only tells doctors where it’s looking, but which past experiences its using to draw its conclusions.
News | Mammography
The First AI Breast Cancer Sleuth That Shows Its Work

January 14, 2022 — Computer engineers and radiologists at Duke University have developed an artificial intelligence ...

Time January 14, 2022
Home
Videos | Artificial Intelligence
VIDEO: Examples of Artificial Intelligence Pulmonary Embolism Response Team Apps

Here are two examples of artificial intelligence (AI) driven pulmonary embolism (PE) response team apps featured by ...

Time January 13, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now